H-NLVPMVATV-NH2

Ref. 3D-PP49587

Informations sur le produit

• Nom: H-NLVPMVATV-NH2

Description

Peptide H-NLVPMVATV-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-NLVPMVATV-NH2 include the following: Identification of HLA-A2 or HLA-A24-restricted CTL epitopes for potential HSP105-targeted immunotherapy in colorectal cancer YU Sawada, H Komori, Y Tsunoda - Oncology , 2014 - spandidos-publications.comhttps://www.spandidos-publications.com/10.3892/or.2013.2941 Procedure for preparing peptide-major histocompatibility complex tetramers for direct quantification of antigen-specific cytotoxic T lymphocytes XH He, LH Xu, Y Liu - World Journal of Gastroenterology: WJG, 2005 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615439/ Combinatorial HLA-peptide bead libraries for high throughput identification of CD8+ T cell specificity X Pan, LC Huang, T Dong , Y Peng, V Cerundolo - Journal of , 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022175913003608 HLA class I-restricted recognition of an HIV-derived epitope peptide by a human T cell receptor alpha chain having a VÎŽ1 variable segment T Ueno , H Tomiyama, M Fujiwara - European journal of , 2003 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200324148 Empty peptide-receptive MHC class I molecules for efficient detection of antigen-specific T cells SK Saini , T Tamhane, R Anjanappa, A Saikia - Science , 2019 - science.orghttps://www.science.org/doi/abs/10.1126/sciimmunol.aau9039 Dipeptides catalyze rapid peptide exchange on MHC class I molecules SK Saini , H Schuster - Proceedings of the , 2015 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1418690112 Identificaiton of novel immunogenic human papillomavirus type 16 E7-specific epitopes restricted to HLA-A* 33; 03 for cervical cancer immunotherapy S Kim, HW Chung , HY Kong, JB Lim - Yonsei medical journal, 2017 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122651/ Recruitment of Oligoclonal Viral-Specific T cells to Kill Human Tumor Cells Using Single-Chain Antibody-Peptide-HLA Fusion Molecules R Noy, M Haus-Cohen, K Oved , T Voloshin - Molecular Cancer , 2015 - AACRhttps://aacrjournals.org/mct/article-abstract/14/6/1327/91951 Altered peptide ligands revisited: Vaccine design through chemically modified HLA-A2-restricted T cell epitopes R Hoppes, R Oostvogels , JJ Luimstra - The Journal of , 2014 - journals.aai.orghttps://journals.aai.org/jimmunol/article/193/10/4803/97379 Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/Mart-1 peptide analogue MJ Maeurer , A Necker, RD Salter - journal of cancer, 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.1580 Synthesis and ex vivo profiling of chemically modified cytomegalovirus CMVpp65 epitopes MA Jones , JK Notta, M Cobbold - Journal of Peptide , 2008 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.930 Glycolipid-peptide conjugate vaccines enhance CD8+ T cell responses against human viral proteins M Speir , A Authier-Hall, CR Brooks , KJ Farrand - Scientific reports, 2017 - nature.comhttps://www.nature.com/articles/s41598-017-14690-5 A novel peptide carrier for efficient targeting of antigens and nucleic acids to dendritic cells M Sioud, G Skorstad, A Mobergslien - The FASEB , 2013 - Wiley Online Libraryhttps://faseb.onlinelibrary.wiley.com/doi/abs/10.1096/fj.12-224758 Human Papillomavirus Type 16 E7 Peptide-Directed CD8+ T Cells from Patients with Cervical Cancer Are Cross-Reactive with the Coronavirus NS2 Protein K Nilges, H Höhn, H Pilch, C Neukirch - Journal of , 2003 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.77.9.5464-5474.2003 Peptide-Major Histocompatibility Complex Class I Tetramers with Enhanced Coreceptor Binding Properties Enable Visualization of Low Avidity Leukemia-Associated JJ Melenhorst, P Scheinberg , E Gostick - 2007 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/110/11/1343/73744 Delivery of large heterologous polypeptides across the cytoplasmic membrane of antigen-presenting cells by the Bordetella RTX hemolysin moiety lacking the J Holubova, J Kamanova, J Jelinek, J Tomala - Infection and , 2012 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/IAI.05711-11 Myeloma-specific multiple peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma and other plasma cell disorders J Bae, R Smith, J Daley, N Mimura, YT Tai - Clinical Cancer , 2012 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/18/17/4850/283647 Novel Myeloma-Specific Multiple Peptides Able to Generate Cytotoxic T Lymphocytes: Potential Therapeutic Application in Multiple Myeloma and Other Plasma Cell J Bae, R Carrasco , AH Lee , R Prabhala , YT Tai - Blood, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006497119619166 A modified peptide stimulation method for efficient amplification of cytomegalovirus (CMV)-specific CTLs G Ruan, L Ma, Q Wen , W Luo, M Zhou - Cellular & Molecular , 2008 - nature.comhttps://www.nature.com/articles/cmi200824 Utilizing TAPBPR to promote exogenous peptide loading onto cell surface MHC I molecules FT Ilca, A Neerincx, MR Wills - Proceedings of the , 2018 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1809465115 Analysis of antigen-specific T-cell responses with synthetic peptides-what kind of peptide for which purpose? F Kiecker, M Streitz, B Ay, G Cherepnev, HD Volk - Human immunology, 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0198885904000539 Dendritic Cells Engineered to Express Defined Allo-HLA Peptide Complexes Induce Antigen-specific Cytotoxic T Cells Efficiently Killing Tumour Cells E Stronen, IW Abrahamsen - Scandinavian , 2009 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-3083.2008.02223.x Peptide-specific CD8+ T-cell evolution in vivo: Response to peptide vaccination with Melan-A/MART-1 E Jager, H Höhn, A Necker, R Förster - journal of cancer, 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.10165 Mutated NPM1 as target for immunotherapy of acute myeloid leukemia DI Van Der Lee, HM Bijen, RS Hagedoorn - Blood, 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006497119806857 In vivo activation of melanoma-specific CD8+ T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cells DE Speiser , D Lienard, MJ Pittet - European journal of , 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/1521-4141(200203)32:3%3C731::AID-IMMU731%3E3.0.CO;2-H Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy D Trivedi, RY Williams, RJ O'Reilly, G Koehne - Blood, 2005 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/105/7/2793/20239 Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer D Nobuoka, T Yoshikawa, M Takahashi - Cancer Immunology , 2013 - Springerhttps://link.springer.com/article/10.1007/s00262-012-1366-6 Random screening of proteins for HLA-A* 0201-binding nine-amino acid peptides is not sufficient for identifying CD8 T cell epitopes recognized in the context of HLA C Pelte, G Cherepnev, Y Wang - The Journal of , 2004 - journals.aai.orghttps://journals.aai.org/jimmunol/article/172/11/6783/80929

• Marque: Biosynth